A recent project collaboration between RTI Health Solutions, the Medical Device Innovation Consortium (MDIC) and the Michael J. Fox Foundation for Parkinson’s Research (MJFF) represents the first time patient preferences on benefits and risks have been used as an explicit means to set significance levels in a clinical trial design. Learn more here. (Source: RTI International, 10/18/16)
